Content uploaded by Zulqarnain Rashid
Author content
All content in this area was uploaded by Zulqarnain Rashid on Aug 30, 2018
Content may be subject to copyright.
Poster: RADAR-base: Epilepsy Case
Study
Zulqarnain Rashid
Institute of Psychiatry,
Psychology & Neuroscience
King’s College London
London, SE5 8AF, UK
zulqarnain.rashid@kcl.ac.uk
Yatharth Ranjan
Institute of Psychiatry,
Psychology & Neuroscience
King’s College London
London, SE5 8AF, UK
yatharth.ranjan@kcl.ac.uk
Callum L Stewart
Institute of Psychiatry,
Psychology & Neuroscience
King’s College London
London, SE5 8AF, UK
callum.stewart@kcl.ac.uk
Richard JB Dobson
Institute of Psychiatry,
Psychology & Neuroscience
King’s College London
London, SE5 8AF, UK
richard.j.dobson@kcl.ac.uk
Sebastian Böttcher
Epilepsy Center, Medical Center
- University of Freiburg
79106 Freiburg, Germany
sebastian.boettcher@uniklinik-
freiburg.de
Amos A Folarin
Institute of Psychiatry,
Psychology & Neuroscience
King’s College London
London, SE5 8AF, UK
amos.folarin@kcl.ac.uk
Permission to make digital or hard copies of part or all of this work for personal or
classroom use is granted without fee provided that copies are not made or distributed
for profit or commercial advantage and that copies bear this notice and the full citation
on the first page. Copyrights for third-party components of this work must be honored.
For all other uses, contact the Owner/Author.
UbiComp/ISWC ’18 Adjunct, October 8-12, 2018, Singapore, Singapore
© 2018 Copyright is held by the owner/author(s).
ACM ISBN 978-1-4503-5966-5/18/10.
https://doi.org/10.1145/3267305.3267578
Abstract
The traditional hospital set-up is not appropriate for long-
term epilepsy seizure detection in naturalistic ambulatory
settings. To explore the feasibility of seizure detection in
such a setting, an in-hospital study was conducted to eval-
uate three wearable devices and a data collection platform
for ambulatory seizure detection. The platform collects and
processes data for study administrators, clinicians and data
scientists, who use it to create models to detect seizures.
For that purpose, all data collected from the wearable de-
vices is additionally synchronized with the hospital EEG and
video, with gold-standard seizure labels provided by trained
clinicians. Data collected by wearable devices shows po-
tential for seizure detection in out-of-hospital based and
ambulatory settings.
Author Keywords
mHealth; mobile app; seizures; epilepsy; brain disorders
ACM Classification Keywords
H.5.m [Human-centered computing (HCC)]: Ubiquitous and
mobile computing.
Introduction
The 22m Euro Remote Assessment of Disease and Re-
lapse - Central Nervous System (RADAR-CNS) Innovative
Medicines Initiative (IMI2) is a research programme aimed
at developing novel methods and infrastructure for measur-
ing major depressive disorder, epilepsy, and multiple sclero-
sis [1]. The goals of RADAR-CNS are achieved through the
RADAR-base platform [2]. RADAR-base aims to provide
a highly extensible platform that enables remote stream-
ing data collection, secure data transmission and scalable
solutions for data storage, management and access. This
paper focuses on the Epilepsy which uses in-hospital de-
ployments of the platform to evaluate the capability of unob-
trusive wearable devices for seizure detection.
Epilepsy is a common serious neurological condition, af-
fecting around 6 million people in Europe. A person may
experience a seizure at any place in any situation (both
night and day). Wearable devices have the potential to de-
tect seizures in daily living conditions allowing the study
of factors and precursors influencing seizure onset. The
downstream opportunity of real-time streaming capabilities
of the RADAR-base platform is especially advantageous
in epilepsy, as it may form the basis of a system to prevent
e.g. sudden unexpected death in epilepsy (SUDEP).
The first application of RADAR-base is currently ongoing
in a trial of approximately 200 patients across two sites.
Patients are recruited prior to undergoing routine inpatient
video-EEG monitoring as part of their conventional care.
Patients are typically recorded for 5-7 days. During this pe-
riod, additional devices are worn by the patient including
the Empatica E4, Biovotion Everion, and Faros 180. The
concurrently recorded video-EEG provides a gold standard
against which the capability of these devices to detect gen-
eralized tonic-clonic and focal seizures can be evaluated.
Figure 1: Data flow for the
epilepsy study, enabling A)
investigation of data quality from
the wearable devices and B)
comparison of clinical information
from new data streams to gold
standard methods (EEG and
video).
Related Work
Many studies measuring non-EEG sensor seizure detec-
tion performance have been conducted [4]. The major-
Figure 2: System Overview: Wearable devices are streaming data
to RADAR-base platform in parallel to video-EEG.
ity of work has used accelerometers, however increasing
availability of different sensors has lead to a greater focus
on multimodal seizure detection [4]. Most studies so far
have been conducted in clinical environments or confined
to a single room and data often manually transferred [3].
However, Vandecasteele et. al. [5] used a commercially
available cloud-based platform to store privacy-sensitive
data. Similarly, Velez et. al. [6] transferred data over Blue-
tooth to a paired tablet device, which then uploaded to a
database over WiFi. However, only potential seizure events
detected by the wearable device were transferred. By con-
trast, the RADAR-base platform, provides a step change in
the capability for continuous high-frequency recordings from
commonly worn devices to be uploaded and processed in
real-time, while guaranteeing full control over the data and
platform architecture.
Methods and Procedures
The RADAR-CNS epilepsy case study involves collecting
data to a locally deployed server hosting the RADAR-base
platform, which synchronously collects data in parallel to
the video-EEG set-up. The requirements fulfilled by the
data collection apparatus are: (i) integration of several dif-
ferent wearable device types for separate collateral data
collection; (ii) capability to stream the device data in real-
time, with little or no patient interaction; (iii) easy manage-
ment of the involved devices for patients and study staff;
(iv) synchronisation of the wearable sensor data with the
video-EEG to an accuracy of 1/10s.
The wearable devices will route their data through an An-
droid device, one per patient. From there it is sent to the
platform server, for processing and availability to study staff.
In turn, the Android devices and video-EEG machines reg-
ularly synchronise with a common time-server. A detailed
clinical set-up is shown in Figures 1 and 2. Figure 3 shows
a patient in a hospital ward wearing several devices, and
the tablet streaming the sensor data to the platform.
The sensor set was established based on the need for sev-
eral parameters of interest such as heart rate variability (via
PPG, EKG), acceleration and electrodermal activity. De-
vices capable of streaming some or all of these included
the Empatica E4 (wrist), Biovotion Everion (upper arm), and
Faros 180 (chest). An additional factor in the choice of de-
vices was the sensor placement, which can affect the qual-
ity of the data produced. For example, there is greater mo-
ment of inertia at the wrist as compared to the upper arm or
chest, so movements generated by spasm during seizures
produce a stronger signal. Conversely, photoplethysmog-
raphy is sensitive to light and motion artefacts, resulting in
significant noise in recordings at the wrist, especially during
motor seizures.
Figure 3: In-hospital epilepsy
patient wearing devices (green),
connected to a tablet (red).
In addition, the selected devices are all capable of connect-
ing to an Android device and streaming the collected raw
data in real-time via a bluetooth connection. Removing the
need for future ambulatory patients to manage data down-
loads in their home and provides clinicians with a real-time
overview of the patient’s condition and research study man-
agement.
The Platform provides structured raw data that can easily
be processed, e.g. to analyse the utility and effectiveness
of the devices in epilepsy studies. Furthermore, raw data
can be used offline to train new seizure detection models,
which can be incorporated into the platform’s real-time data
processing infrastructure to test them on new data as it is
being collected. Thus the platform also provides the possi-
bility for real-time seizure detection and alerting.
Results
The presented set-up has been successfully tested in an
ongoing clinical trial at the video-EEG monitoring units of
both the Clinical Neurophysiology Department at King’s
College Hospital London and the Epilepsy Center at the
University Hospital of Freiburg. As of June 2018, 125 pa-
tients have been enrolled at both of the sites.
Where possible, participants have concurrently worn all
three devices, the Empatica, Biovotion and Faros. Figure 4
shows a three-minute segment of acceleration, blood vol-
ume pulse and electrodermal activity during a focal seizure
event. The motor component can clearly be seen in the
accelerometry, as well as the significant impact of the pa-
tients movements on the blood volume pulse signal, which
is generated by the photoplethysmography sensor of the
Empatica E4. Characteristic changes in all signals have
been observed during seizure events of several different
types (generalized tonic-clonic and focal seizures).
Figure 4: Empatica E4 sensor data. The shaded area indicates a
focal seizure with a motor component. (a) Accelerometer. (b)
Photoplethysmogram. (c) Electrodermal activity.
Conclusion and Future Work
We are investigating the potential of wearable devices as
clinically valuable alternatives to complement hospital-
based technologies, and as a prerequisite to future am-
bulatory passive remote monitoring of patients in their home
environment. The capabilities of the RADAR-base plat-
form are sufficient for an in-hospital study of patients with
epileptic seizures, and a further out-of-hospital ambulatory
is under planning.
Acknowledgements
This work has received support from the EU/EFPIA Inno-
vative Medicines Initiative Joint Undertaking 2 (RADAR-
CNS grant No 115902). We would like to acknowledge
The Hyve and RADAR-CNS Consortium (http://www.radar-
cns.org/partners) for their support. The Authors receive
funding support from the National Institute for Health Re-
search (NIHR) Biomedical Research Centre at South Lon-
don and Maudsley NHS Foundation Trust and KCL.
References
[1] 2017. RADAR-CNS. https://www.radar-cns.org/. (2017).
[2] 2018. RADAR-base. https://radar-base.org/. (2018).
[3] Judith Andel, Constantin Ungureanu, Johan Arends,
Francis Tan, Johannes Van Dijk, George Petkov,
Stiliyan Kalitzin, Thea Gutter, Al Weerd, Ben Vled-
der, Roland Thijs, Ghislaine Thiel, Kit Roes, and Frans
Leijten. 2017. Multimodal, automated detection of noc-
turnal motor seizures at home: Is a reliable seizure
detector feasible. Epilepsia Open (2017).
[4] Anouk Van de Vel, Kris Cuppens, Bert Bonroy, Milica
Milosevic, Katrien Jansen, Sabine Van Huffel, Bart
Vanrumste, Patrick Cras, Lieven Lagae, and Berten
Ceulemans. 2016. Non-EEG seizure detection sys-
tems and potential SUDEP prevention: State of the art:
Review and update. Seizure (2016).
[5] Kaat Vandecasteele, Thomas De Cooman, Ying Gu,
Evy Cleeren, Kasper Claes, Wim Van Paesschen,
Sabine Van Huffel, and Borbala Hunyadi. 2017. Auto-
mated Epileptic Seizure Detection Based on Wearable
ECG and PPG in a Hospital Environment. Sensors 17,
10 (2017).
[6] Mariel Velez, Robert S. Fisher, Victoria Bartlett, and
Scheherazade Le. 2016. Tracking generalized tonic-
clonic seizures with a wrist accelerometer linked to an
online database. Seizure (2016).